#USA #Veeva Systems #Pleasanton #Veeva Falcon #Copli

Veeva Systems Acquires Copli to Launch Veeva Falcon MLR

In a significant move for the life sciences industry, Veeva Systems (NYSE: VEEV) recently announced the acquisition of Copli, a pioneering company in agentic medical, legal, and regulatory (MLR) solutions. This acquisition aims to boost efficiency in content review processes through the new offering, Veeva Falcon MLR.

Understanding Veeva Falcon MLR

Veeva Falcon MLR is not just another product in the market; it is designed to transform the MLR landscape profoundly. This innovative solution utilizes advanced automation to minimize manual efforts, aiming to reduce MLR review workload by a staggering 70% or more within five years. Companies in the life sciences sector have long been bogged down by cumbersome review processes, which often lead to delays in delivering critical information to healthcare professionals and patients. Veeva Falcon MLR addresses these challenges head-on.

With its agentic MLR™ capabilities, Veeva Falcon MLR assists marketing teams, MLR groups, and agencies in rigorously reviewing promotional and medical materials. The system conducts compliance checks against approved labels and local regulations, allowing reviewers to focus on more strategic tasks rather than getting lost in repetitive, manual checks.

Jacob Scheel-Bech, CEO of Copli, expressed the significance of this advancement, stating, "Our progress with agentic MLR marks a fundamental shift in the review and approval of commercial and medical content. Being part of Veeva enables us to expand our vision for MLR transformation. Veeva Falcon MLR provides rapid compliance capabilities to the industry with intelligent agents that integrate seamlessly with Veeva PromoMats."

The Need for Streamlined Processes

The MLR process has historically represented a major bottleneck in the journey to get vital information into the hands of healthcare professionals and patients alike. Emma Hyland, VP at Veeva Commercial Content, highlighted the importance of this new solution, noting, "With Veeva Falcon MLR, our clients can accelerate the entire review cycle, automating routine work that enables reviewers to become strategic advisors."

This automation permits teams to shift their focus toward tasks that drive value, ultimately benefiting patient care. By implementing Veeva Falcon MLR, organizations can significantly decrease turnaround times, ensuring that crucial content reaches the intended audience without unnecessary delay.

Join the Upcoming Webinar

For those interested in learning more about Veeva Falcon MLR and its capabilities, Veeva Systems invites you to participate in an upcoming webinar scheduled for July 9 at 10 a.m. ET. This session aims to provide depth into how Veeva Falcon MLR transforms content review and compliance processes.

To register for this informative event, visit FalconMLR.veeva.com.

About Veeva Systems

Veeva is recognized as a leading cloud platform for the life sciences sector, offering software solutions, artificial intelligence, data frameworks, and consultancy services. Committed to fostering innovation and product excellence, Veeva serves over 1,500 customers ranging from the largest pharmaceutical companies worldwide to emerging biotechnology firms. As a public benefit corporation, Veeva also adheres to a mission to balance stakeholder interests, including clients, employees, shareholders, and the communities they serve.

For further information, visit veeva.com and stay updated on their groundbreaking technologies and initiatives.

Forward-Looking Statements

It's important to note that this announcement contains forward-looking statements regarding the anticipated outcomes and benefits of Veeva's acquisition of Copli. These projections are based on current plans, estimates, and expectations and are subject to risks that could cause actual results to differ materially. We encourage stakeholders to review Veeva's filings with the SEC for a detailed understanding of associated risks.